More Medical Science Monitor Journal's Impact Trend, Prediction, Ranking & Key Factor Analysis are all in Acadmeic Accelerator. Although most inhibitors reported in the literature were at high titers (mean: 67.7 Bethesda Units/ml), their prognosis was good, as they disappeared in most cases after suspension of the involved drug or after immunosuppressive therapy (complete remission rate: 83.3%). The Medical Science Monitor Latest Journal's Impact IF 2021-2022 is 2.649. In particular there is increased evidence for an association between acquired hemophilia A and interferon given as treatment for hepatitis C virus infection.
A total of 34 cases were identified, mostly related to a variety of agents, including antibiotics and psychiatric and immunomodulatory drugs. No impact factor infomation for this journal.
Med sci monit impact factor manual#
Based on electronic and manual searches of the published literature, this review examines the current knowledge on drug-induced factor VIII autoantibodies. Latest PubMed content for: Med Sci Monit. ISSN: 2325-4416 (Electronic) 2325-4394 (Print) 2325-4394 (Linking) Impact Factor. Prompt diagnosis of this acquired bleeding disorder is essential for appropriate management aimed to control hemorrhage and suppress the inhibitor. Articles from Medical Science Monitor : International Medical Journal of Experimental and Clinical Research are provided here courtesy of International Scientific Information, Inc. MCQ (90 questions): 20 medicine & surgery, 40 anaesthesia & pain, 10 clinical measurement, 20 ITU. However, in approximately 50 percent of the patients no underlying disorder can be identified. SAQs (12 on clinical anaesthesia) Afternoon paper. Acquired hemophilia A is most frequently associated with autoimmune diseases, solid tumors, lymphoproliferative diseases, pregnancy, and drug reactions. Acquired hemophilia A is an uncommon but potentially life-threatening hemorrhagic disorder caused by the onset of autoantibodies against coagulation factor VIII.
0 kommentar(er)
